MENU
IXJ
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

IXJ stock forecast, quote, news & analysis

The investment seeks to track the S&P Global 1200 Health Care (Sector) Capped IndexTM... Show more

Category: #Health
Interact to see
Advertisement
A.I.Advisor
published price charts
IXJ
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for IXJ with price predictions
Oct 21, 2026

IXJ in upward trend: 10-day moving average crossed above 50-day moving average on October 19, 2026

The 10-day moving average for IXJ crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on IXJ as a result. In 68 of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.

The Moving Average Convergence Divergence (MACD) for IXJ just turned positive on October 12, 2026. Looking at past instances where IXJ's MACD turned positive, the stock continued to rise in 39 of 49 cases over the following month. The odds of a continued upward trend are 80%.

IXJ moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +4.38% 3-day Advance, the price is estimated to grow further. Considering data from situations where IXJ advanced for three days, in 260 of 324 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IXJ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.

IXJ broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for IXJ entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Unitedhealth Group (NYSE:UNH), Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Intuitive Surgical (NASDAQ:ISRG).

Industry description

The investment seeks to track the S&P Global 1200 Health Care (Sector) Capped IndexTM. The fund seeks to track the investment results of the S&P Global 1200 Health Care (Sector) Capped IndexTM (the “underlying index”), which measures the performance of companies that S&P Dow Jones Indices LLC (the “index provider” or “SPDJI”), a subsidiary of S&P Global, Inc., deems to be a part of the healthcare sector of the economy and that SPDJI believes are important to global markets. The underlying index is a subset of the S&P Global 1200, which is designed to measure the performance of large-capitalization stocks from major global markets, as determined by SPDJI.

Market Cap

The average market capitalization across the iShares Global Healthcare ETF (IXJ) ETF is 106.27B. The market cap for tickers in the group ranges from 556.27M to 1.13T. LLY holds the highest valuation in this group at 1.13T. The lowest valued company is HKD at 556.27M.

High and low price notable news

The average weekly price growth across all stocks in the iShares Global Healthcare ETF (IXJ) ETF was 11%. For the same ETF, the average monthly price growth was 24%, and the average quarterly price growth was 299%. CRL experienced the highest price growth at 14%, while DXCM experienced the biggest fall at -4%.

Volume

The average weekly volume growth across all stocks in the iShares Global Healthcare ETF (IXJ) ETF was -19%. For the same stocks of the ETF, the average monthly volume growth was -7% and the average quarterly volume growth was -10%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 65
P/E Growth Rating: 45
Price Growth Rating: 30
SMR Rating: 57
Profit Risk Rating: 69
Seasonality Score: 25 (-100 ... +100)
IXJ in upward trend: 10-day moving average crossed above 50-day moving average on October 19, 2026